Emi Noguchi

10PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 22, 2024
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer.

Emi Noguchi, Takashi Yamanaka, Hirofumi Mukai

|Aug 14, 2024
Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine.

Rui Kitadai, Tatsunori Shimoi, Shu Yazaki

|Dec 15, 2022
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer.

Shu Yazaki, Roberto Salgado, Tatsunori Shimoi

|Oct 17, 2022
High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer.

Shu Yazaki, Yuki Kojima, Hiroshi Yoshida

|Apr 03, 2021
Breast Cancer Brain Metastasis-Overview of Disease State, Treatment Options and Future Perspectives.

Chikashi Watase, Sho Shiino, Tatsunori Shimoi

|Sep 21, 2020
Safety and Evidence of Off-Label Use of Approved Drugs at the National Cancer Center Hospital in Japan.

Seiko Bun, Kan Yonemori, Hiroko Sunadoi

Pageof 2

Frequent Collaborators

6 joint publications

Tatsunori Shimoi

5 joint publications

Yasuhiro Fujiwara

4 joint publications

Kan Yonemori

3 joint publications

Tadaaki Nishikawa